These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29536561)

  • 21. The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.
    Li SY; Li J; Dong XH; Teng GG; Zhang W; Cheng H; Gao W; Dai Y; Zhang XH; Wang WH
    Helicobacter; 2021 Aug; 26(4):e12804. PubMed ID: 33860967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of bismuth for antibiotic-resistant Helicobacter pylori strains eradication: A systematic review and meta-analysis.
    Han Z; Li Y; Kong Q; Liu J; Wang J; Wan M; Lin M; Lin B; Zhang W; Ding Y; Wang S; Mu Y; Duan M; Zuo X; Li YQ
    Helicobacter; 2022 Dec; 27(6):e12930. PubMed ID: 36156332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study.
    Phiphatpatthamaamphan K; Vilaichone RK; Siramolpiwat S; Tangaroonsanti A; Chonprasertsuk S; Bhanthumkomol P; Pornthisarn B; Mahachai V
    Asian Pac J Cancer Prev; 2016; 17(4):1903-7. PubMed ID: 27221874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori antimicrobial resistance in a pediatric population.
    Silva GM; Silva HM; Nascimento J; Gonçalves JP; Pereira F; Lima R
    Helicobacter; 2018 Oct; 23(5):e12528. PubMed ID: 30091503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
    Hu S; Zhou Y; Deng Y; Bo Y; Chen X; Yang W; Shi R; Zhao W; Hou Z; Hu J; Liu J; Zhang X; Yong H; Wang P; Li F; Qi H; Wang X; Jin L; Cui T; Yong H; Li X; Yang B; Yu Y; Ma B; Fu L; Wang X; Ma Z; Tang N; You Y; Guo J; Yu X; Yao L; Gao R; Li Y; Xin R; Liu J; Cao Z; Li H; Ma L; Ma S; Cao Y; Tang Y; Liu J; Hao Q; Li X; Li X; Mu R; Niu M; Su X; Gao H
    Helicobacter; 2023 Jun; 28(3):e12960. PubMed ID: 37042045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication.
    De Francesco V; Zullo A; Fiorini G; Saracino IM; Pavoni M; Vaira D
    J Antimicrob Chemother; 2019 Mar; 74(3):772-774. PubMed ID: 30476134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.
    Caliskan R; Tokman HB; Erzin Y; Saribas S; Yuksel P; Bolek BK; Sevuk EO; Demirci M; Yılmazli O; Akgul O; Kalayci F; Cakan H; Salih B; Bal K; Kocazeybek B
    Rev Soc Bras Med Trop; 2015; 48(3):278-84. PubMed ID: 26108005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzales B; Zampeli E; Grivas E; Spiliadi C; Sotiropoulou M; Petraki K; Zografos K; Laoudi F; Sgouras D; Mentis A; Kasapidis P; Michopoulos S
    Eur J Intern Med; 2016 Jul; 32():84-90. PubMed ID: 27134145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic susceptibility of Helicobacter pylori in Iceland.
    Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
    Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 32. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
    Romano M; Cuomo A; Gravina AG; Miranda A; Iovene MR; Tiso A; Sica M; Rocco A; Salerno R; Marmo R; Federico A; Nardone G
    Gut; 2010 Nov; 59(11):1465-70. PubMed ID: 20947881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
    Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
    Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced?
    Baylina M; Muñoz N; Sánchez-Delgado J; López-Góngora S; Calvet X; Puig I
    Helicobacter; 2019 Jun; 24(3):e12584. PubMed ID: 30990575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori antibiotic resistance in a Dutch region: trends over time.
    Janssen MJ; Hendrikse L; de Boer SY; Bosboom R; de Boer WA; Laheij RJ; Jansen JB
    Neth J Med; 2006 Jun; 64(6):191-5. PubMed ID: 16788217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Antibiotic-Resistant
    Khien VV; Thang DM; Hai TM; Duat NQ; Khanh PH; Ha DT; Binh TT; Dung HDQ; Trang TTH; Yamaoka Y
    Gut Liver; 2019 Sep; 13(5):483-497. PubMed ID: 31009957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.
    Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E
    Digestion; 1998; 59(6):646-50. PubMed ID: 9813387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.
    Crone J; Granditsch G; Huber WD; Binder C; Innerhofer A; Amann G; Hirschl AM
    J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):368-71. PubMed ID: 12604976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit.
    Fraser AG; Moore L; Hackett M; Hollis B
    Aust N Z J Med; 1999 Aug; 29(4):512-6. PubMed ID: 10868529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.